The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Open accessAbstract
Inhibitory receptors for MHC class I molecules increase the threshold of lymphocyte activation. Natural Killer (NK) cells express a large number of such inhibitory receptors, including the human killer Ig-like receptors (KIR). However, activating members of the KIR family have poorly defined ligands and functions. Here we describe the use of activating KIR tetramer reagents as probes to detect their ligands. Infection of cells with Epstein–Barr virus leads to expression of a detectable ligand for the activating receptor KIR2DS1. In this case, KIR2DS1 interacts with up-regulated peptide–MHC class I complexes on Epstein–Barr virus-infected cells in a transporter associated with antigen processing (TAP)-dependent manner. In tetramer-based cellular assays and direct affinity measurements, this interaction with MHC class I is facilitated by a broad spectrum of peptides. KIR2DS1 and its inhibitory homologue, KIR2DL1, share sensitivity to peptide sequence alterations at positions 7 and 8. These results fit a model in which activating and inhibitory receptors recognize the same sets of self-MHC class I molecules, differing only in their binding affinities. Importantly, KIR2DS1 is not always sufficient to trigger NK effector responses when faced with cognate ligand, consistent with fine control during NK cell activation. We discuss how our results for KIR2DS1 and parallel studies on KIR2DS2 relate to the association between activating KIR genes and susceptibility to autoimmune disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
Natural Killer Cell Signaling Pathways
Vivier, E., Nunès, J. A., & Vély, F. (2004) · Science · doi:10.1126/science.1103478 · Cited by 751
Self-citationKrug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727
Natural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Self-citationUse of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C Antigens
Parham, P., Barnstable, C. J., & Bodmer, W. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.1.342 · Cited by 673
Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection
Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R. C., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L. R., Scalzo, A. A., & Yokoyama, W. M. (2001) · Science · doi:10.1126/science.1060042 · Cited by 627
Immune functions encoded by the natural killer gene complex
Yokoyama, W. M., & Plougastel, B. F. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1055 · Cited by 565
Stam, N. J., Spits, H., & Ploegh, H. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.7.2299 · Cited by 541
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Self-citationHsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Cooper, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.012 · Cited by 434
Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O., & Wagtmann, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.571 · Cited by 422
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G., & Sun, P. D. (2000) · Nature · doi:10.1038/35014520 · Cited by 404
Self-citationLee, S.-H., Girard, S., Macina, D., Busà, M., Zafer, A., Belouchi, A., Gros, P., & Vidal, S. M. (2001) · Nature Genetics · doi:10.1038/ng0501-42 · Cited by 403
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Cross-Talk between Activated Human NK Cells and CD4+ T Cells via OX40-OX40 Ligand Interactions
Zingoni, A., Sornasse, T., Cocks, B. G., Tanaka, Y., Santoni, A., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3716 · Cited by 283
van der Slik, A. R., Koeleman, B. P. C., Verduijn, W., Bruining, G. J., Roep, B. O., & Giphart, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2639 · Cited by 224
Understanding how combinations of HLA and KIR genes influence disease
Rajagopalan, S., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050499 · Cited by 220
Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271203 · Cited by 213
Self-citationAbi-Rached, L., & Parham, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042558 · Cited by 211
Rajagopalan, S., & Long, E. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1523 · Cited by 206
Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
REBAÏ, N., & MALISSEN, B. (1983) · Tissue Antigens · doi:10.1111/j.1399-0039.1983.tb01176.x · Cited by 196
Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
Valés-Gómez, M., Reyburn, H. T., Erskine, R. A., & Strominger, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14326 · Cited by 175
A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors
Boyington, J. C., & Sun, P. D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00030-5 · Cited by 172
Self-citationAllen, R. L., Raine, T., Haude, A., Trowsdale, J., & Wilson, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5543 · Cited by 164
Łuszczek, W., Mańczak, M., Cisło, M., Nockowski, P., Wiśniewski, A., Jasek, M., & Kuśnierczyk, P. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.05.008 · Cited by 155
Desrosiers, M., Kielczewska, A., Loredo‐Osti, J. C., Adam, S. G., Makrigiannis, A. P., Lemieux, S., Pham, T. H. M., Lodoen, M. B., Morgan, K., Lanier, L. L., et al. (2005) · Nature Genetics · doi:10.1038/ng1564 · Cited by 149
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1
de la Salle, H., Zimmer, J., Fricker, D., Angénieux, C., Cazenave, J., Okubo, M., Maeda, H., Plebani, A., Tongio, M., Dormoy, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5687 · Cited by 143
Kinetics of Interaction of HLA-C Ligands with Natural Killer Cell Inhibitory Receptors
Valés‐Gómez, M., Reyburn, H. T., Mandelboim, M., & Strominger, J. L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80616-0 · Cited by 139
Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., & Muto, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22517.x · Cited by 135
Maenaka, K., Juji, T., Nakayama, T., Wyer, J. R., Gao, G., Maenaka, T., Zaccai, N., Kikuchi, A., Yabe, T., Tokunaga, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28329 · Cited by 134
Katz, G., Markel, G., Mizrahi, S., Arnon, T. I., & Mandelboim, O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7260 · Cited by 126
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
Katz, G., Gazit, R., Arnon, T. I., Gonen‐Gross, T., Tarcic, G., Markel, G., Gruda, R., Achdout, H., Drize, O., Merims, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1819 · Cited by 115
Blanca, I., Bere, E. W., Young, H. A., & Ortaldo, J. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6132 · Cited by 102
Cross-talk between dendritic cells and natural killer cells in viral infection
Andrews, D. M., Andoniou, C. E., Scalzo, A. A., van Dommelen, S. L. H., Wallace, M. E., Smyth, M. J., & Degli‐Esposti, M. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.040 · Cited by 102
Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)
Saulquin, X., Gastinel, L. N., & Vivier, É. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021624 · Cited by 91
Self-citationSantos, S. G., Powis, S. J., & Arosa, F. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408794200 · Cited by 66
Self-citationRecognition of infected cells by natural killer cells
Carayannopoulos, L. N., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.003 · Cited by 60
Ciccone, E., Pende, D., Nannl, L., Donato, C. D., Viale, O., Beretta, A., Vitale, M., Sivori, S., Moretta, A., & Moretta, L. (1995) · International Immunology · doi:10.1093/intimm/7.3.393 · Cited by 38
Self-citationBaran‐Marszak, F., Fagard, R., Girard, B., Camilleri‐Broët, S., Zeng, F., Lenoir, G., Raphaël, M., & Feuillard, J. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000035025.51772.2b · Cited by 28
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationHuman NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
Self-citationActivation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650
Cooley, S., Weisdorf, D. J., Guethlein, L. A., Klein, J. P., Wang, T., Le, C. T., Marsh, S. G. E., Geraghty, D., Spellman, S., Haagenson, M. D., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283051 · Cited by 591
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wang, W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00368 · Cited by 567
Metadata
- Authors
- Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., Moretta, A., Sun, P. D., Ugolini, S., & Vivier, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-09-02
- Volume
- 102
- Issue
- 37
- Pages
- 13224-13229
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2138781831
- Cited by
- 406
- References
- 52
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.